Intravenous (IV) Iron Utilization Among Pregnant Women

Basic Details
Date Posted
Tuesday, September 1, 2020
Status
Complete
Medical Product
intravenous (IV) iron
Description

In this report we estimated intravenous (IV) iron utilization among women with live-birth delivery, stillbirth, or pre-eclampsia/eclampsia event in the Sentinel Distributed Database (SDD). 

The study period included data from January 1, 2016 to July 31, 2019. We distributed this request to 15 Data Partners on December 3, 2019.

Deliverables (1)
Sentinel Modular Program Report: Intravenous (IV) Iron Utilization Among Pregnant Women
Additional Details
FDA Center
CDER
Time Period
January 1, 2016 - July 31, 2019
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Females 15 to 45 years of age
Data Sources
Sentinel Distributed Database (SDD)
Related Links
ICPE 2020: Utilization of IV Iron among Pregnant Women with Live Births or Stillbirths; A Study in the Sentinel Distributed Database
Sentinel Drug Assessment: Infed (Iron Dextran), Venofer (Iron Sucrose), Feraheme (Ferumoxytol), Injectafer (Ferric Carboxymaltose), Monoferric (Ferric Derisomaltose) & Exposure in Pregnancy